

Partnering at Grünenthal – Building a Future Together
Grünenthal has built a strong platform and unique capabilities to acquire, successfully integrate and maximize the performance of established brands and even entire portfolios. Since 2017, Grünenthal closed successful acquisitions of established brands and a Joint Venture with a total deal value of more than € 2.3 billion, outperforming benchmark M&A in the pharmaceutical market.

Partnering to grow our business and invest in the future
At Grünenthal we know that successful partnerships are all about respect, trust and commitment to collaboration. For every deal, big or small, we’re looking for like-minded partners who share our passion for bringing life-changing medicines to patients around the world.
As a fully integrated pharmaceutical company, our expertise and infrastructure cover R&D, manufacturing, quality control, supply, regulatory and commercial functions; this enables us to handle deals across the full lifecycle of a product.
Global Partnerships
countries
Strong network
partner companies
As we look to the future, partnering will continue to form a core element of our growth strategy, allowing us to:
- Foster Innovation with our industry-leading expertise in neurobiology, including sensory biology, hypersensitivity, neuroinflammation, and neurodegeneration. We seek to apply this expertise to promising compounds that may transform patients' lives.
- Diversify our commercial portfolio with established brands that address critical unmet medical needs
- Expand our global reach so we can serve more patients around the world
Ready to Collaborate? Let’s Talk.
If you are interested in partnering with us, we’d love to hear from you.






